Translating metabolomics to cardiovascular biomarkers.
Translating metabolomics to cardiovascular biomarkers.
复制标题
DOI:
10.1016/j.pcad.2012.06.004
复制
发表时间:
2012-07
影响因子:
9.1
通讯作者:
Tang, W. H. Wilson
中科院分区:
文献类型:
--
作者:
Senn, Todd;Hazen, Stanley L.;Tang, W. H. Wilson
Metabolomics is the systematic study of the unique chemical fingerprints of small-molecules, or metabolite profiles, that are related to a variety of cellular metabolic processes in a cell, organ, or organism. While mRNA gene expression data and proteomic analyses do not tell the whole story of what might be happening in a cell, metabolic profiling provides direct and indirect physiologic insights that can potentially be detectable in a wide range of biospecimens. Although not specific to cardiac conditions, translating metabolomics to cardiovascular biomarkers has followed the traditional path of biomarker discovery from identification and confirmation to clinical validation and bedside testing. With technological advances in metabolomic tools (such as nuclear magnetic resonance spectroscopy and mass spectrometry) and more sophisticated bioinformatics and analytical techniques, the ability to measure low-molecular-weight metabolites in biospecimens provides a unique insight into established and novel metabolic pathways. Systemic metabolomics may provide physiologic understanding of cardiovascular disease states beyond traditional profiling, and may involve descriptions of metabolic responses of an individual or population to therapeutic interventions or environmental exposures.
登录
查看更多内容
影响因子:
24
作者:
Mayr, Manuel;Yusuf, Shamil;Camm, A. John
通讯作者:
Camm, A. John
影响因子:
20.1
作者:
Barth, AS;Merk, S;Nabauer, M
通讯作者:
Nabauer, M
影响因子:
158.5
作者:
Hochman, JS;Sleeper, LA;LeJemtel, TH
通讯作者:
LeJemtel, TH
影响因子:
24
作者:
Tang, W. H. Wilson;Wang, Zeneng;Cho, Leslie;Brennan, Danielle M.;Hazen, Stanley L.
通讯作者:
Hazen, Stanley L.
影响因子:
1.8
作者:
Nicholson, JK;Lindon, JC;Holmes, E
通讯作者:
Holmes, E